• contribute to the protection and promotion of public health, including new activities like orphan medicinal products • provide a high standard of technical and organisational support to CPMP meetings • provide legal, regulatory and procedural guidance to all involved parties • provide support to the Commission decision-taking process • coordinate the handling of parallel distribution notifications within 30 days • coordinate practical arrangements for inclusion of Iceland and Norway in EMEA activities • further strengthen the collaboration with central and eastern European countries in the framework of recognition of centrally authorised medicinal products including maintenance and provision of pharmacovigilance information • support the Mutual Recognition Facilitation Group (MRFG) and its expanding activities • provide technical and organisational support to EMEA Herbal Medicinal Products Working Party • support participation of the EMEA in the Joint Action on new synthetic drugs together with the European Monitoring Centre for Drugs and Drug Addiction and Europol